BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 95 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $17,973,000 | +14.7% | 450 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $15,669,000 | -73.0% | 450 | -66.7% | 0.00% | -70.0% |
| Q4 2015 | $58,010,000 | -88.4% | 1,350 | -92.7% | 0.01% | -85.3% |
| Q2 2014 | $501,456,000 | +6.9% | 18,600 | +2.8% | 0.07% | +6.2% |
| Q1 2014 | $469,152,000 | +11.0% | 18,100 | -7.2% | 0.06% | -1.5% |
| Q4 2013 | $422,565,000 | +8.5% | 19,500 | -2.5% | 0.06% | +3.2% |
| Q3 2013 | $389,400,000 | – | 20,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 82,800 | $2,468,000 | 3.37% |
| NORTHPOINTE CAPITAL LLC | 123,764 | $4,845,000 | 0.52% |
| EAM Investors, LLC | 78,901 | $3,089,000 | 0.36% |
| Elk Creek Partners, LLC | 83,357 | $3,263,000 | 0.34% |
| TFS CAPITAL LLC | 68,551 | $2,684,000 | 0.26% |
| Ativo Capital Management LLC | 13,075 | $512,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 58,623 | $2,295,000 | 0.13% |
| Hillsdale Investment Management Inc. | 10,480 | $410,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 63,647 | $2,492,000 | 0.10% |
| Palo Alto Investors LP | 50,436 | $1,975,000 | 0.10% |